Fate Therapeutics Inc (FATE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.56
• Market Cap: $170.72M
• EPS: $-1.21
• 52-Week High: $1.94
• 52-Week Low: $0.66

Market Sentiment

Fate Therapeutics Inc currently has a Bullish sentiment score of 0.22.

About Fate Therapeutics Inc

Fate Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on developing next-generation programmed cellular immunotherapies for cancer and immune disorders. Utilizing its proprietary induced pluripotent stem cell (iPSC) technology, Fate is pioneering the creation of off-the-shelf therapies designed to enhance immune system responses. The company boasts a strong pipeline of therapeutic candidates aimed at addressing both h...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Fate Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FATE pay dividends?

Fate Therapeutics Inc (FATE) does not currently pay a regular dividend.

What is FATE's market cap?

Fate Therapeutics Inc (FATE) has a market capitalization of $170.72M with a current stock price of $1.56.